AntiRadical Therapeutics
Pre-clinicalUnderstanding the complexities of aging and the associated medical challenges, this article explores the innovative anti-aging drug SE3TPL developed by Reivtia Bioinnovative. It examines the biological mechanisms of aging, the need for tailored healthcare solutions for older adults, and the promising therapeutic applications of SE3TPL in addressing age-related conditions such as neurodegenerative diseases and chronic inflammation. Discover how advancements in anti-aging therapies can improve ...
About
Understanding the complexities of aging and the associated medical challenges, this article explores the innovative anti-aging drug SE3TPL developed by Reivtia Bioinnovative. It examines the biological mechanisms of aging, the need for tailored healthcare solutions for older adults, and the promising therapeutic applications of SE3TPL in addressing age-related conditions such as neurodegenerative diseases and chronic inflammation. Discover how advancements in anti-aging therapies can improve ...
Funding History
2Total raised: $8.7M
Company Info
Contact
Sectors
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile